Axoft Secures $55M Series A to Advance Clinical Trials Globally for its Bio-Inspired, Implantable...
Axoft, a neurotechnology company, today announced it has raised an oversubscribed $55 million Series A led by C.P. Group Innovation. Alumni Ventures, the Sta...
businesswire.com